drugset / Trial / NCT01042782
Phase I Study of Daily RAD001 in Combination With Mitomycin C in Patients With Advanced Gastric Cancer or Cancer of the Esophagogastric Junction
NaSingle-groupOpen-labelTreatment
Summary
Patients with advanced gastric cancer are treated with a combination of RAD001 (everolimus) and Mitomycin C.
Timeline
- Start
- 2008-01
- Primary completion
- 2012-08
- Completion
- 2012-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Everolimus | Small molecule | 5 mg | Oral |
| Subject | Everolimus | Small molecule | 7.5 mg | Oral |
| Subject | Everolimus | Small molecule | 10 mg | Oral |
| Background | Mitomycin C | Other / unclassified | 5 mg/m2 | Intravenous |